Navigation Links
Free Access to Taxotere Instills New Hope among Early Stage Breast Cancer Patients

National Institute for Health and Clinical Excellence said that 10,000 breast cancer patients who are in their early stage of the disease would be given free access to// Taxotere, a chemotherapy drug.

This drug was initially given to those suffering from late-stage breast cancer. Statistics said that this initiative would save more than 600 lives of patients suffering from breast cancer. The guidance comes nine months after the Scottish equivalent of Nice, the Scottish Medicines Consortium, approved the use of Taxotere for Scottish women in the early stages of the disease.

David Miles, consultant oncologist at London Bridge hospital, said that this drug has the potential to prevent the deaths of hundreds of women with breast cancer. He said that this is an important step taken towards the treatment of early stage breast cancer in the UK. Numerous clinical trials confirm that Taxotere-containing regimens are very effective in the treatment of breast cancer. Hence from November every primary care trust will be obliged to offer the drug to breast cancer patients whose cancer has spread to their lymph nodes.


'"/>




Page: 1

Related medicine news :

1. Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients.
2. Scots Do Not Have Access To Proper Dental Care
3. Children In Scotland Denied Access To Dental Care
4. Speedier Access To Advances In Breast Cancer Sought For Patients
5. Patients Have Right To Access Medical Case Papers: Bombay High Court
6. AIDS Deaths On The Rise Due To Low Access To Antiretroviral Treatment
7. Easy Access To Healthcare Services Essential For Better Survival Rates
8. People Affected By HIV Positive Urge For Better Treatment Access
9. Singapore To Offer More Patients Access To Chronic Disease Management Programs
10. Lack of Proper Emergency Access during the Run Led To the Death of Four Runners
11. Large Scale Free Access On Usage Of HIV Drugs Could Help In Fighting Its Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... 2016 , ... Global Lyme Alliance (GLA), a leading nonprofit ... has named Scott Santarella as its new CEO. , Santarella is former ... San Francisco, where he successfully helped to grow the organization from a regional ...
(Date:5/24/2016)... ... May 24, 2016 , ... Researchers ... of protocols designed to reduce bleeding complications from percutaneous coronary intervention (PCI). The ... Interventions (SCAI) in Orlando, FL, document a 40% reduction in risk-adjusted bleeding event ...
(Date:5/24/2016)... ... May 24, 2016 , ... Design Concepts ... ‘El Centro del Quinto Sol Wheel Park’ in Pueblo, Colorado. This park was ... offer something special for this often overlooked neighborhood. Located at 609 E. 6th ...
(Date:5/24/2016)... ... May 24, 2016 , ... Celebration is in ... kicked off its 5th Annual Photo Contest. The label contest is underway, and ... year's prizes include a GoPro Hero4, a 40-inch high-definition flat-screen television, an Apple ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... On the ... took the time to summarize the weight loss process: , New patients have a ... Composition Analysis (BCA) to get accurately evaluated. , Body Composition Analysis, There are 15 ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Experts from various ... Medicine and the role of technology in innovative ... The First International Conference of VPS-Penn Medicine opened in ... and presence of Sheikh Nahyan bin Mubarak Al Nahyan, Minister ... Medicine, which helps provide personalized medicine and tailor-made healthcare in ...
(Date:5/23/2016)... , May 23, 2016 The ... USD 5.0 billion by 2022, according to a new ... of medical waste coupled with the lack of centralized ... expected to drive the demand for reprocessed medical devices ... as compared to that of the original device is ...
(Date:5/22/2016)... DUBLIN , May 23, 2016 ... to develop its anti-fibrotic and anti-inflammatory compound DS102 ... well as in non-alcoholic steatohepatitis (NASH) patients. ... is significantly sequestered in lung tissue and has ... tissue after oral administration. The Company will publish ...
Breaking Medicine Technology: